A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

NCT02835105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Associated Diarrhea (CDAD)

Interventions

DRUG: Surotomycin
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC